News | July 03, 2024
LG Chem enters Chinese osteoarthritis treatment market
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Signs MoUs with Shri Krishna Ayush University and Dabur India
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
The collaboration aims to bolster healthcare entrepreneurship
EBITDA before special items falls 1.3 percent to € 4.41 billion
First-quarter 2024 revenues totaled $14.9 billion, a decrease of $3.6 billion, or 20%, compared to the prior-year quarter
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
Sales reflect continued strong growth in oncology and vaccines
Subscribe To Our Newsletter & Stay Updated
